Aligos Therapeutics shares owned by Versant Venture Management
Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Versant Venture Management
from 13F filings
Historical chart of Versant Venture Management investment in Aligos Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aligos Therapeutics held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Aligos Therapeutics by Versant Venture Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $1.5M | 2.3M | 0.66 |
2023-09-30 | $1.7M | 2.3M | 0.75 |
2023-06-30 | $2.3M | 2.3M | 0.97 |
2023-03-31 | $2.0M | 2.3M | 0.87 |
2022-12-31 | $2.2M | 2.3M | 0.95 |
2022-09-30 | $2.6M | 2.3M | 1.10 |
2022-06-30 | $2.8M | 2.3M | 1.21 |
2022-03-31 | $5.0M | 2.3M | 2.15 |
2021-12-31 | $28M | 2.3M | 11.87 |
2021-09-30 | $36M | 2.3M | 15.51 |
2021-06-30 | $47M | 2.3M | 20.39 |
2021-03-31 | $75M | 3.3M | 22.74 |
2020-12-31 | $91M | 3.3M | 27.65 |
More positions owned by Versant Venture Management
View all positions for Versant Venture Management